Actionable Insights to Accelerate Awareness, Influence & Impact

Evaluate Your Communications Landscape in Less than Six Weeks

 

Crowded markets. Complex science. High stakes. To stand out and deliver in today’s rapidly changing MedTech sector, you need more than compelling messaging. Success requires a communications strategy grounded in insight, evidence, and opportunity.

 

BRG’s Brand Accelerator delivers a fast, focused evaluation of your communications landscape. In six weeks or less, we assess your narrative, channels, audiences, and competitive environment to identify what’s working, what’s missing, and where your brand story can break through.

 

With decades of health communications expertise for leading MedTech, device and health brands, BRG identifies the voices shaping your category and pinpoints where credibility is built – and lost. The result is a clear, prioritized path to stronger awareness, relevance, and trust.

 

Whether you’re preparing for pivotal data, deepening clinician and patient engagement, or strengthening corporate reputation, BRG’s Brand Accelerator delivers a data-informed blueprint that aligns with business objectives and bottom-line impact.

Clarity for Decisions Ahead

 

Whether you’re pre-launch, scaling commercialization, or expanding into new patient sectors, BRG’s Brand Accelerator gives leadership teams a clear view of how their brand story is landing — and where focus, refinement, or restraint will matter most.

Name(Required)

Our Six-Week Program Will Help You Identify:

Gaps and opportunities in your current communications strategy

Media, influencers, and stakeholder audiences that matter most in your category

How your evidence, science, and outcomes are showing up externally

How your brand and narrative compare to key competitors

Ready to unlock your brand’s communications advantage and transform your presence in the market? Fill out the form to start the conversation.

Building a Brand Reputation Program to Support Product & Partner Milestones

Tasso, an innovative health technology company, is transforming traditional blood collection using a new patient-centric approach that is simple, convenient and virtually painless. Tasso challenged BRG to increase brand awareness and support the company’s continued growth including partnership visibility and FDA milestones. BRG built the ongoing custom program based on insights gained through our trusted Communications Diagnostic approach.

 

Results:

Built a messaging strategy that highlights Tasso’s unique offerings and support for healthcare diagnostics companies while staying compliant with FDA regulatory guidelines

Increased brand awareness and credibility through strategic partnership announcements

Elevated executive thought leadership through a multi-faceted initiative with media opportunities, award entries, and speaker’s bureau development

Defining a Game-Changing Hypertension Innovation for Millions of Patients

When Medtronic, a global leader in medical technology, prepared to advance its hypertension technology through critical clinical, regulatory and reimbursement milestones, the company faced a crowded, highly scrutinized category dominated by aggressive competitive claims and patient skepticism.

To ground decisions in data, BRG conducted a comprehensive Communications Diagnostic during key moments – mapping competitive narrative landscape, auditing media and stakeholder perceptions, pressure-testing core messaging and identifying “right to win” areas beyond clinical endpoints.

 

Results:

Identified areas to differentiate narrative, leading with clinical rigor and patient empathy and aligned messaging across clinical, regulatory, investor and payer audiences.

Built and executed a multi-year integrated communications strategy, driving consistent high-quality coverage and sustained share of voice across financial, trade and national media.

Led integrated launch communications in 2024, securing 8,000+ placements and 3B impressions while strategically reframing media narratives to distinguish from competitor technologies.

Conditioned priority markets ahead of private payer coverage decisions, strengthening the foundation for long-term access and adoption.